Scholarly Index
Mark J. O’Connor
AstraZeneca (United Kingdom); 20,882 total citations; 172 total publications; best world rank #81
AstraZeneca (United Kingdom)
20,882Total citations
172Total publications
68H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| PARP inhibition in cancer therapy | Lifetime | 81 | GB 12 | 98.70 |
| DNA Repair Mechanisms | Lifetime | 300 | GB 29 | 98.49 |
| PARP inhibition in cancer therapy | 2021-2025 | 177 | GB 22 | 94.17 |
| DNA Repair Mechanisms | 2021-2025 | 277 | GB 33 | 89.84 |